Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells.
about
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of CancerRegulation of Bim in Health and DiseaseThe fibronectin III-1 domain activates a PI3-Kinase/Akt signaling pathway leading to αvβ5 integrin activation and TRAIL resistance in human lung cancer cells.Fibroblast-derived neuregulin 1 promotes compensatory ErbB3 receptor signaling in mutant BRAF melanomaBRAF Inhibition Generates a Host-Tumor Niche that Mediates Therapeutic Escape.Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors.β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast CancerRMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma.Loss of phosphodiesterase 4D mediates acquired triapine resistance via Epac-Rap1-Integrin signaling.Activity-Based Protein Profiling Shows Heterogeneous Signaling Adaptations to BRAF Inhibition.Immunogenic, cellular, and angiogenic drivers of tumor dormancy--a melanoma view.Crosstalk signaling in targeted melanoma therapy.The safety and efficacy of cobimetinib for the treatment of BRAF V600E or V600K melanoma.The role of phenotypic plasticity in the escape of cancer cells from targeted therapy.Identification of the Serine Biosynthesis Pathway as a Critical Component of BRAF Inhibitor Resistance of Melanoma, Pancreatic, and Non-Small Cell Lung Cancer Cells.Prognostic value of increased integrin-beta 1 expression in solid cancers: a meta-analysis.CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer.
P2860
Q26774789-BAC83D8F-4B78-4BC5-8043-34F40607AB25Q26781203-819516A3-D8DE-45A8-BC6E-44F85B158F44Q36092975-6041FDE3-1BF1-40F1-8867-2297DFF4B58EQ36115818-323AFD48-2EBD-4DAC-BB51-F2F794D94FA0Q36289114-D75DC23E-628A-4D52-B8EF-F44F4F193454Q37190236-DDF68721-6C7C-45A9-A5DA-E7B8D1028869Q37286353-7A36CAB8-36CD-47D9-87AC-963391853DE9Q37392814-B941505C-28C6-4D2F-87AF-7647357819BAQ37708984-E4C06366-2684-405F-B1F5-FD8FF4971D77Q38439387-59D88C86-1C5B-4147-B52C-E9D05F673E1DQ38619615-A757E81C-1613-4606-BFFF-D03C69DC045BQ38757522-B5BD417A-99E7-4880-A039-EA5A6DDD7CDFQ38843111-051ABC44-C369-42A2-BBD8-7EA7082DD254Q38878911-FF7901C0-BC6C-45E6-A954-42F4B9471401Q51004855-D2AD4129-3678-4856-B82C-A430C5FA137AQ52595279-1F7AFAD1-2472-4844-B9A9-350098C0C4B0Q55513244-50824A00-1FA7-4DC8-966E-ECD4BAD164F8
P2860
Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Fibronectin induction abrogate ...... 600E/PTEN-null melanoma cells.
@ast
Fibronectin induction abrogate ...... 600E/PTEN-null melanoma cells.
@en
type
label
Fibronectin induction abrogate ...... 600E/PTEN-null melanoma cells.
@ast
Fibronectin induction abrogate ...... 600E/PTEN-null melanoma cells.
@en
altLabel
Fibronectin induction abrogate ...... V600E/PTEN-null melanoma cells
@en
prefLabel
Fibronectin induction abrogate ...... 600E/PTEN-null melanoma cells.
@ast
Fibronectin induction abrogate ...... 600E/PTEN-null melanoma cells.
@en
P2093
P2860
P356
P1433
P1476
Fibronectin induction abrogate ...... V600E/PTEN-null melanoma cells
@en
P2093
G T Gibney
I V Fedorenko
J A Sosman
J L Messina
J M Koomen
K B Dahlman
P2860
P2888
P304
P356
10.1038/ONC.2015.188
P407
P577
2015-06-15T00:00:00Z